
10x Genomics TXG
$ 20.97
0.29%
Quarterly report 2024-Q3
added 10-29-2024
10x Genomics Operating Income 2011-2026 | TXG
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income 10x Genomics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -265 M | -168 M | -52.3 M | -534 M | -30.6 M | -111 M | -18.4 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -18.4 M | -534 M | -168 M |
Quarterly Operating Income 10x Genomics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41.5 M | -41.7 M | -61.5 M | -94.8 M | -63.4 M | -52 M | - | - | -63.1 M | -41.7 M | - | -15.9 M | -10.3 M | -10.2 M | - | -65.3 M | -39.4 M | -19.9 M | - | -9.1 M | -10.4 M | -3.04 M | - | -14.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -3.04 M | -94.8 M | -36.6 M |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-46.8 M | - | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B | ||
|
American Well Corporation
AMWL
|
-105 M | $ 5.55 | -1.42 % | $ 89.1 M | ||
|
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | ||
|
Schrödinger
SDGR
|
-167 M | $ 11.52 | 1.05 % | $ 846 M | ||
|
Phreesia
PHR
|
-136 M | $ 11.52 | 2.49 % | $ 629 M | ||
|
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | ||
|
Teladoc Health
TDOC
|
-263 M | $ 5.52 | -0.9 % | $ 973 M | ||
|
Evolent Health
EVH
|
3.64 M | $ 2.3 | 1.55 % | $ 216 M | ||
|
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | ||
|
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | ||
|
MTBC
MTBC
|
11.3 M | - | -0.58 % | $ 51.7 M | ||
|
Premier
PINC
|
1.12 M | - | - | $ 2.33 B | ||
|
GoodRx Holdings
GDRX
|
65.8 M | $ 2.06 | -0.24 % | $ 795 M | ||
|
SCWorx Corp.
WORX
|
-1.26 M | $ 0.14 | 7.38 % | $ 204 K | ||
|
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | ||
|
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | ||
|
HealthStream
HSTM
|
21.3 M | $ 21.24 | 0.05 % | $ 645 M | ||
|
Akerna Corp.
KERN
|
-17.7 M | - | - | $ 161 M | ||
|
Zhongchao
ZCMD
|
-341 K | $ 1.78 | -1.11 % | $ 9.27 M | ||
|
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | ||
|
Health Catalyst
HCAT
|
-161 M | $ 1.09 | -0.91 % | $ 76.2 M | ||
|
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | ||
|
HealthEquity
HQY
|
322 M | $ 83.31 | 1.01 % | $ 7.18 B | ||
|
Omnicell
OMCL
|
337 K | $ 35.35 | 1.17 % | $ 1.63 B | ||
|
OptimizeRx Corporation
OPRX
|
-26.4 M | $ 7.0 | -2.51 % | $ 120 M | ||
|
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M | ||
|
Progyny
PGNY
|
15.8 M | $ 17.91 | 0.9 % | $ 1.54 B | ||
|
So-Young International
SY
|
-624 M | $ 2.88 | -9.87 % | $ 229 M | ||
|
Veeva Systems
VEEV
|
916 M | $ 180.16 | 1.17 % | $ 29.5 B |